Leucine Rich Repeat Containing Protein 15 (LRRC15) Antibody

169€ (20 µg)
Este producto es parte de LRRC - Leucine-rich repeat-containing protein
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leucine Rich Repeat Containing Protein 15 (LRRC15) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx308815
tested applications
ELISA, IHC, IF/ICC

Descripción del producto

LRRC15 Antibody is a Rabbit Polyclonal against LRRC15.

Documents del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

NCBI AccessionNP_001128529.2, NM_001135057.2, NP_570843.2, NM_130830.4
AliasLIBLeucine-rich repeat protein induced by beta-amyloid homolog ,hLib
AvailabilityShipped within 5-10 working days.
BackgroundAntibody anti-LRRC15
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
CategoryPrimary Antibodies
ClonalityPolyclonal
ConjugationUnconjugated
Dry IceNo
FormLiquid
Gene ID131578
HostRabbit
Immunogen TargetLeucine Rich Repeat Containing Protein 15 (LRRC15)
IsotypeIgG
NameLeucine Rich Repeat Containing Protein 15 (LRRC15) Antibody
Price169
ProviderAbbexa
PurificationPurified by Protein G.
Purity> 95%
ReactivityHuman
Recommended DilutionIHC: 1/20 - 1/200, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Referenceabx308815
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
StatusRUO
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Tested ApplicationsELISA, IHC, IF/ICC
UniProt IDQ8TF66

Descripcion del producto en español

Background en español

LRRC15 is a collagen-binding protein with a significant role in regulating extracellular matrix (ECM) remodeling and cell-matrix interactions it is widely expressed in stromal cells and tumor-associated fibroblasts where it participates in modulating cell adhesion and migration particularly in cancer and wound healing contexts LRRC15 has been identified as a critical component of the tumor microenvironment facilitating tumor progression and metastasis by influencing ECM organization and stiffness it is also involved in immune modulation through its interactions with immune cell receptors recent studies indicate its expression is upregulated in fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and systemic sclerosis implicating it in pathological ECM deposition and remodeling LRRC15's potential as a therapeutic target is being explored particularly in oncology where its expression correlates with resistance to immune checkpoint inhibitors and poor prognosis in several cancers ongoing research aims to clarify its regulatory mechanisms in ECM biology and its cross-talk with other signaling pathways driving tissue repair and fibrosis

Related Products

abx037098

Leucine Rich Repeat Containing Protein 15 (LRRC15) Antibody

Rabbit Polyclonal against the LRRC15 protein.

Ver Producto
abx214850

Leucine-Rich Repeat-Containing Protein 15 (LRRC15) Antibody

LRRC15 Antibody is a Rabbit Polyclonal against LRRC15.

Ver Producto
abx241560

Leucine-Rich Repeat-Containing Protein 15 (LRRC15) Antibody

LRRC15 Antibody is a Rabbit Polyclonal against LRRC15.

Ver Producto